VINORELBINE\VINORELBINE for Non-small cell lung cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 163 adverse event reports in the FDA FAERS database where VINORELBINE\VINORELBINE was used for Non-small cell lung cancer.
Most Reported Side Effects for VINORELBINE\VINORELBINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Malignant neoplasm progression | 158 | 11.6% | 26 | 25 |
| Neutropenia | 151 | 11.1% | 36 | 22 |
| Disease progression | 105 | 7.7% | 26 | 14 |
| Death | 98 | 7.2% | 98 | 14 |
| Off label use | 94 | 6.9% | 11 | 31 |
| Nausea | 89 | 6.5% | 8 | 23 |
| Anaemia | 88 | 6.5% | 17 | 21 |
| Drug ineffective | 81 | 6.0% | 21 | 7 |
| Diarrhoea | 77 | 5.7% | 14 | 13 |
| Vomiting | 71 | 5.2% | 10 | 18 |
| Thrombocytopenia | 69 | 5.1% | 20 | 14 |
| Febrile neutropenia | 67 | 4.9% | 15 | 31 |
| Fatigue | 66 | 4.9% | 6 | 15 |
| Dyspnoea | 64 | 4.7% | 24 | 18 |
| Pyrexia | 61 | 4.5% | 5 | 43 |
Other Indications for VINORELBINE\VINORELBINE
Breast cancer metastatic (171)
Breast cancer (106)
Hodgkin's disease (99)
Product used for unknown indication (95)
Her-2 positive breast cancer (86)
Lung neoplasm malignant (73)
Lung adenocarcinoma (40)
Invasive ductal breast carcinoma (33)
Diffuse large b-cell lymphoma (28)
Chemotherapy (27)
Other Drugs Used for Non-small cell lung cancer
NIVOLUMAB (9,987)
CARBOPLATIN (7,939)
PEMBROLIZUMAB (6,893)
OSIMERTINIB (6,358)
PEMETREXED (5,179)
PACLITAXEL (4,609)
ATEZOLIZUMAB (4,459)
BEVACIZUMAB (4,136)
DURVALUMAB (3,396)
ERLOTINIB (3,359)